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 AGA   -  Appropriate for gestational age. 
 CNS            -  Central nervous system. 
 COA      -  Coarctation of aorta. 
 CBG    -  Capillary blood glucose. 
 DM      -  Diabetes mellitus. 
 5% D     -  5 % dextrose. 
 (eg)             -  Example. 
 Etc               -  Excreta. 
 ECG      -  Electrocardiography. 
 FBS       -  Fasting blood sugar. 
 FPF            -  Fibroblast pneumocyte factor. 
 FIG          -  Figure. 
 GDM      -  Gestational diabetes mellitus. 
 GIT      -  Gastrointestinal tract. 
 GCT   -  Glucose challenge test. 
 HbA1C         -  Glycosylated haemoglobin. 
 HR     -  Hour. 
 HOCM     -  Hypertrophic cardiomyopathy. 
 HCT        -  Hematocrit. 
 IDDM   -  Insulin dependent diabetes mellitus. 
 IUD     -  Intrauterine death. 
 LGA    -  Large for gestational age. 
 LN          -  Labour naturalis. 
 LSCS        -  Lower segment caesarean section. 
 NICU       -  Neonatal intensive care unit. 
 OGTT         -  Oral glucose tolerance test. 
 PDA           -  Patent ductus arteriosus. 
 PCV       -  Packed cell volume. 
 PPBS      -  Post prandial blood sugar. 
 RDS    -  Respiratory distress syndrome. 
 RBS       -  Random blood sugar. 
 RBC   -  Red blood cell. 
 RL          -  Ringer lactate. 
 SGA  -  Small for gestational age. 
 TGA         -  Transposition of great arteries. 
 WKS   -  Weeks. 
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INTRODUCTION 
 Diabetes mellitus during pregnancy is associated with adverse 
foetal and maternal outcomes. Improved health care and management of 
diabetes have reduced the incidence of adverse perinatal outcome in 
infants of diabetic mothers. Appropriate management of blood sugar in 
diabetic mother will maintain good glycemic control. In such cases, 
pregnancy outcomes could be expected comparable to the general 
population. 
 In general, abnormalities of carbohydrate metabolism occur 
frequently during pregnancy and about 3 to 5% of pregnant mothers will 
show glucose intolerance. Approximately 90% of these women will 
develop gestational diabetes.            
Diabetes mellitus in pregnancy is classified into 2 types. They are 
           1. Pregestational diabetes. 
           2. Gestational diabetes. 
 Complications that occur in neonates born to diabetic mothers can 
be classified as those due to poor glycemic control in the 1st trimester 
(e.g.) congenital anomalies, and those due to poor glycemic control 
during the 3rd trimester (e.g.) metabolic complications. Even pre 
conceptional glucose control is essential to avoid congenital anomalies in 
neonates. 
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 Management of diabetes in pregnant women includes watchful 
monitoring and treatment during antenatal period and treatment during 
delivery. 
Tests done during the first trimester in diabetic mothers include: 
 HbA1C. 
 Ultrasonography. 
 Ophthalmic examination. 
 Renal function test. 
 Thyroid profile. 
Tests done during second trimester in diabetic mothers include: 
 Maternal serum testing for neural tube defects. 
 Ultrasonographic survey including foetal echocardiography. 
 In high risk cases - Chorionic villous sampling and 
amniocentesis. 
Tests done during third trimester in diabetic mothers include: 
 Monthly ultrasonographic examination for foetal growth 
monitoring. 
 Weekly foetal surveillance using non stress test or 
biophysical profile. 
 To achieve good glycemic control, diabetic mothers are advised 
dietary modifications, exercise and medications. The objective of 
treatment is to maintain the fasting capillary glucose under 95mg/dl and 
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the 1hr and 2hr postprandial capillary glucose under 140mg/dl and 
120mg/dl respectively. Normally Insulin therapy is advised to maintain 
glycemic control in pregnant women with diabetes. It has been 
demonstrated that human insulin analogues do not cross the placenta. 
Most recently, the oral hypoglycaemic agent Glyburide has been shown 
to be effective in the management of GDM, but it remains untested in pre 
gestational diabetes. Data are emerging that Metformin may also be used 
as an alternative to achieve glycemic control during pregnancy.  
 Glycosylated haemoglobin is a useful method to find out the 
glycemic control in the previous three months. In this study I have used 
this method to estimate the maternal third trimester glycemic control and 
compared it with the incidence of complications in babies born to them.  
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AIM AND OBJECTIVES 
 To study the pattern of complications in newborn born to diabetic 
mothers. 
 To assess the correlation between HbA1C level in diabetic mothers 
and complications in babies born to them. 
 To emphasize the importance of strict glycemic control during 
pregnancy in diabetic mothers 
 To emphasize the need to monitor the babies born to diabetic 
mothers in their early neonatal period to recognise the complications 
early and treat them. 
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REVIEW   OF   LITERATURE 
 Diabetes mellitus is a disease of glucose intolerance which 
complicates 1% of the total pregnancies, making it the most common 
medical disorder that occurs during pregnancy. Diabetes mellitus in 
pregnancy presents as some peculiar complications in both mother and 
newborn. Planning in advance is important if one wants to have a baby 
without diabetes induced complications1, 2. Management of diabetes in 
pre gestational diabetes should aim at strict blood sugar control even 
before conception. Studies show that about 50% of gestational diabetic 
mothers develop Type - 2 Diabetes, later in their life3. 
 Due to the recent advancements in the management of diabetes 
during pregnancy, there has been reduction in mortality and morbidity in 
neonates born to diabetic mothers. But perinatal mortality still continues 
at rates of 3 – 5 %, compared to about 1 – 2 % mortality noted in general 
population2. Incidences of complications such as neonatal 
hypoglycaemia, hyperbilirubinemia, respiratory distress syndrome, 
macrosomia, congenital malformation, polycythemia, hypocalcemia and 
birth injuries are still frequent in neonates born to diabetic mothers. These 
complications can be reduced by observing good glycemic control in 
diabetic mothers and the burden of perinatal mortality can be reduced. 
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Incidence 
 Incidence of diabetes mellitus is about 3 – 10 % of all pregnancies. 
Among that, gestational diabetes accounts for about 90% of cases of 
diabetes complicating pregnancy2. Mothers with gestational diabetes are 
individuals who have a genetic or metabolic predisposition towards 
diabetes and those who are not able to counter the diabetogenic changes 
that occur during pregnancy. Type - 2 diabetes accounts for about 8% of 
cases of diabetes mellitus in pregnancy. 
 Recent data shows that the prevalence of gestational diabetes has 
increased about 10 – 100 % 4. A true increase in prevalence of gestational 
diabetes, aside from its adverse consequences in infants in the newborn 
period might also reflect to the pattern of increased diabetes and obesity 
especially in the babies. Therefore, meticulous screening of pregnant 
mothers for gestational diabetes and management of diabetic mothers in 
order to achieve a good glycemic control are mandatory for the healthy 
society in future. Maternal complications that occur during and after 
pregnancy could also be reduced. 
Physiology 
 Pregnancy by itself is a diabetogenic state. The reason for this is 
the hormonal changes that occur during pregnancy. Most important of 
these is the increase in insulin resistance. This is mainly attributed to the 
increase in the placental hormone, the human placental lactogen that is 
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found in increased amounts during the third trimester of the pregnancy. 
This explains why gestational diabetes occurs more after 26 weeks2, 4. 
Changes in carbohydrate metabolism during pregnancy: 
 As a result of many hormonal changes that occur during 
pregnancy, the carbohydrate metabolism in pregnancy undergoes many 
changes. The most important reason why pregnancy increases the 
diabetogenic tendency of asymptomatic mother is the progressive 
increase in insulin resistance that occurs during pregnancy. Other reasons 
for this increased diabetogenic tendency are the increased lipolysis and 
the changes in gluconeogenesis which usually occurs during pregnancy2, 
4, 5
. During early pregnancy, there is increased sensitivity to insulin and 
the patients tend to have an increased incidence of hypoglycaemia. This 
increased insulin sensitivity is due to high levels of estrogen. Fasting 
blood sugar is usually lower than normal from 10th to 16th week of 
pregnancy, and then the blood sugar values rise gradually up to 32 weeks. 
During the 3rd trimester, there is an increase in insulin resistance which 
leads to increased blood sugar values. Increased level of human placental 
lactogen hormone is the main reason for the insulin resistance that occurs 
during the second half of pregnancy5. Other causes are increased insulin 
catabolism by placental insulinases and the relative dysfunction of insulin 
by various hormones that increase during pregnancy. This is the reason 
for the increased incidence of gestational diabetes after 26 wks of 
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pregnancy and the need to screen for gestational diabetes during that 
period is emphasized12. 
Table.1 
Diabetogenic Hormones in Pregnancy 13 
Hormone 
Peak elevation 
(wks) 
Diabetogenic 
potency 
            Prolactin 10 Weak 
        Estradiol 26 Very weak 
          Cortisol 26 Very strong 
     Progesterone 32 Strong 
 
Effects of Diabetes on Pregnancy: 
Maternal: 
 Mostly carbohydrate imbalance is asymptomatic in pregnancy. In 
some diabetic mothers with microalbuminuria, worsening albuminuria 
during pregnancy is at increased risk for preeclampsia (About 10 – 25 % 
increased risk) 2, 14, 15. 
 Infection - Incidence of chorioamnionitis and postpartum 
endometritis is increased in pregnancies complicated by diabetes. 
 Diabetic gastroparesis – This exacerbates nausea and vomiting that 
is usually present in normal pregnancies which in turn lead to the need for 
extra nutritional support for diabetic mothers2. 
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 Diabetic retinopathy may develop or retinopathy that is already 
present may worsen during pregnancy complicated by diabetes. Patients 
who have pre-existing renal disease are at high risk for further decline in 
renal function during pregnancy. Post partum bleeding is high due to 
exaggerated uterine distension. 
 Hyperglycemia / Hypoglycemia and Ketoacidosis are common. 
Coronary artery disease and thromboembolic complications may occur. 
Major birth defects in infant of diabetic mother: 
 The incidence of foetal malformations is 4-10 times more in 
individuals with uncontrolled diabetes at the time of conception and 
normal blood glucose during the preconception period and during the 
entire period of organ development in foetus should be maintained6, 8. 
CNS-SKELETAL  - Neural tube defects, Sacral agenesis,  
     Holoprocencephaly. 
CARDIOVASCULAR -  HOCM, TGA, COA, PDA. 
RENAL    -  Renal agenesis, Hydronephrosis. 
GIT    -  Duodenal atresia, Lazy left colon 
     syndrome. 
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Metabolic Complications: 
        Pederson’s theory of HYPERGLYCEMIC – HYPERINSULINISM 7 
is quoted to explain the metabolic complications in the newborn born to 
diabetic mothers. According to this, uncontrolled maternal 
hyperglycaemia causes foetal hyperglycaemia. This in turn stimulates 
foetal islet cells to produce hyperinsulinemia. This foetal 
hyperinsulinemia is said to be the primary cause for macrosomia, 
respiratory distress syndrome and other metabolic complications. 
Hypoglycemia  
 Hypoglycemia is seen in 25 – 40 % of babies born to diabetic 
mothers2, 15, 21. Neonatal hypoglycemia is the most frequently presenting 
complication among those seen in infants born to diabetic mothers. 
According to the recent guidelines, blood glucose value of < 40mg/dl is 
hypoglycaemia. It is mainly due to excessive insulin production by 
pancreatic islet cells of the newborn, which are enlarged and hyperactive 
due to maternal hyperglycaemia which causes foetal hyperglycaemia and 
stimulates the islet cells. Meticulous regulation of blood sugars, 
especially during the second and third trimester of pregnancy may reduce 
these complications. Mostly it is asymptomatic, but the various 
presenting features are 
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 Jitteriness  
 Seizure 
 Lethargy 
 Refusal of feeds 
 Respiratory distress 
 Cyanosis 
 Shock 
 Incessant cry etc.  
These babies should be admitted in neonatal intensive care unit. 
Periodic blood glucose monitoring is a must. In asymptomatic cases, 
frequent breast feeding is advised. In symptomatic cases, IV 10% 
Dextrose 2ml/kg should be given as a bolus. This should be followed up 
with glucose infusion starting from a glucose infusion rate of 4 to 6 
mg/kg/min. This is to prevent rebound hypoglycemia. Hypoglycemia 
which persists even with a glucose infusion rate of 12 mg/kg/min is called 
resistant hypoglycemia. In such cases drugs such as Glucagon, 
Hydrocortisone and Diazoxide are used 16, 17. 
Hypocalcemia  
 Hypocalcemia is seen in 25 – 30% of babies born to diabetic 
mothers.21 Mostly it is asymptomatic. Usually it presents during first 
three days of life. Contributory factors may be prematurity, birth asphyxia 
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and inappropriate response of Parathormone to hypocalcemia. It may 
present as 
 Jitteriness 
 Apnoeic attacks   
 Hypotonia 
 Seizures.  
 Ionised calcium value < 4 mg/dl is required to label as 
hypocalcemia. But S. Calcium (total) value < 7mg/dl is also taken as 
hypocalcemia16,18,20. Hypocalcemia in well babies born to diabetic 
mothers, usually resolves without any treatment and we do not routinely 
measure serum calcium in asymptomatic infants. Hypomagnesemia may 
coexist16,17. 
Hypomagnesemia should be considered in infants with 
hypocalcemia, because hypocalcemia does not respond until the 
hypomagnesemia is corrected. Babies found to have hypocalcemia are 
admitted in NICU and Inj.10% Calcium gluconate is given as a slow 
intravenous injection and then maintained with oral calcium of 75 -100 
mg/kg/day. 
Hyperbilirubinemia 
Hyperbilirubinemia occurs in 20 – 25 % of infants born to diabetic 
mothers2,16,17,21. It is seen with increased frequency in infants born to 
diabetic mothers because of the following reasons,                                              
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 Bilirubin production is accelerated.      
 Insulin causes increased stimulation of erythropoietin.  
 The life span of red blood cells is reduced because of less 
deformable cell membranes due to glycosylation of erythrocyte cell 
membrane. This leads to destruction of red cells as they traverse 
through the micro circulation. 
 Other factors that may be a cause for jaundice are prematurity, 
defective hepatic conjugation of bilirubin and an increased 
enterohepatic circulation of bilirubin due to poor feeding. 
 Infants born to diabetic mothers with good glycemic control, have 
fewer problems with hyperbilirubinemia. The increasing gestational 
age of infants at delivery leads to decreased incidence of 
hyperbilirubinemia. Hyperbilirubinemia in infants born to diabetic 
mothers is diagnosed and treated as in any other infant. Treatment is 
individualised in each neonate and depends on the value of serum 
bilirubin, the infant’s gestational age, weight of the neonate, clinical 
status and day of life. Either phototherapy or exchange transfusion is 
done according to the need.  
Polycythemia 
Polycythemia is seen in 30 - 35 % of infants born to diabetic 
mothers. Chronic foetal hypoxia leads to polycythemia that occurs in 
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infants born to diabetic mothers16,17,19,21. Polycythemia is defined as 
venous hematocrit of over 65%. 
A venous hematocrit of over 64% or more at 2 hrs of age. 
An umbilical venous or arterial hematocrit of over 63% or more. 
The mean venous hematocrit of term infants is 53% in cord blood, 60% at 
2 hours of age, 57% at 6 hours of age, and 52% at 12 to 18 hours of age. 
Symptoms 
 Poor feeding. 
 Lethargy. 
 Apnoea. 
 Seizures. 
 Cyanosis. 
 Respiratory distress. 
 Increased jaundice. 
Hematocrit > 65% can result in intravascular thrombosis.19 
Thrombosis has been described in the arterial system, including the aorta 
but is particularly prone to occur in the veins. Polycythemia leads to 
increased incidence of hyperbilirubinemia due to the increased red blood 
cell destruction during a particular period of time. Treatment is 
PARTIAL EXCHANGE TRANSFUSION.  Indicated in asymptomatic 
babies with PCV above 70% and in symptomatic babies with PCV above 
15 
 
65%.It is done by exchanging blood of the baby with normal saline. The 
amount to be exchanged is calculated using the formula 
VOLUME OF EXCHANGE IN ML = (OBSERVED HCT-DESIRED 
HCT)/OBSERVED HCT × BODY WT × BLOOD VOLUME PER KG. 
MACROSOMIA 
Foetal macrosomia is defined as foetal weight equal to or larger 
than 4kg. Macrosomia may be the reason for the increased incidence of 
caesarean section or obstetric trauma such as Fracture clavicle, Erb’s 
palsy and Klumpkey’s palsy as a result of shoulder dystocia2,16,17. 
Macrosomia is found to be associated with elevated third trimester 
maternal blood sugar, hyperinsulinemia and hypoglycaemia. Hence all 
pregnant diabetic mothers should undergo ultrasound examinations every 
4 weeks, starting at 20 weeks of pregnancy to estimate the foetal weight 
and to follow the foetal growth. The first indication of developing 
macrosomia is an increase in abdominal circumference than other 
measurements, resulting in elevated head to abdomen and femur to 
abdomen ratios. The estimated foetal weight may be in the 60th to 80th 
percentile between 26 and 32 weeks but by the end of the pregnancy will 
be above the 90th percentile. Primary management of macrosomia 
includes caesarean section if the foetal weight exceeds 4 kg. All 
macrosomic babies should be admitted and kept under observation to 
look for other complications such as hypoglycemia. 
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Respiratory Distress Syndrome 
Respiratory distress syndrome is seen in 3 – 5 % of babies born to 
diabetic mothers21. One of the causes of respiratory distress in infant of 
diabetic mothers is hyaline membrane disease. Insulin antagonises the 
stimulatory effects of cortisol on fibroblasts to induce the synthesis of 
fibroblast pneumocyte factor (FPF) which in turn inhibits type-1 cells and 
phosphatidyl choline production. Measurement of phosphatidyl glycerol 
alone or in combination with the lecithin, phosphatidyl choline may be a 
more reliable indicator of lung maturity in diabetic pregnancies than the 
lecithin - sphingomyelin ratio alone16,20. Besides RDS, there are many 
other causes of respiratory distress in infants born to diabetic mothers. 
These include 
Causes of respiratory distress in infants born to diabetic mothers 
 Transient tachypnea of the newborn. 
 Polycythemia. 
 Birth asphyxia. 
 Hypertrophic cardiomyopathy. 
 Other cardiac or pulmonary anomalies. 
 Pneumonia. 
 Pneumothorax. 
 Diaphragmatic hernia. 
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Effects of pregnancy on diabetes14,15: 
 More insulin is necessary to achieve metabolic control. 
 Progression of diabetic retinopathy. 
 Worsening of diabetic nephropathy. 
 Increased risk of death for patients with diabetic cardiomyopathy. 
 These patients have a tendency toward metabolic instability and 
will need frequent blood glucose monitoring, continuous adjustments in 
therapy, and a highly regulated lifestyle. For diabetic patients who 
already have organ damage, pregnancy may accelerate end organ disease, 
requiring intensive testing and therapeutic procedures. The complex 
interaction between abnormal carbohydrate metabolism and pregnancy 
should be clearly explained to each patient immediately after the 
diagnosis is made and prior to pregnancy when the patient has pre 
gestational diabetes. 
Classification of diabetes mellitus in pregnancy 
Pre gestational 
 Type-1 
 Type-2 
Gestational22 
 Diet controlled 
 Insulin requiring 
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Type-1 
 Diabetes is a condition in which body makes no insulin or so little 
insulin that the body cannot change blood sugar into energy. This occurs 
during childhood or adolescence20, 22. 
Type-2  
 Diabetes is a condition in which body makes too little insulin or 
cannot use the insulin it makes to change blood sugar into energy. This 
occurs at child bearing age20, 22. 
 GDM- Diabetes first diagnosed in a pregnant woman usually 
resolves after pregnancy. 
Whites classification 
 Named after PRISCILLA WHITE2, who did research on the effect 
of diabetes mellitus on perinatal outcome is widely used to assess 
maternal and foetal risk. 
 CLASS A1 -  GDM, Diet controlled. 
 CLASS A2 -  GDM, Medication controlled. 
 CLASS B - Onset at age > 20 yrs /Duration <10yrs. 
 CLASS C -  Onset at 10 - 19 yrs / Duration 10-19 yrs. 
 CLASS D - Onset before 10yrs / Duration >20yrs. 
 CLASS E - Overt diabetes with calcified pelvic vessels. 
 CLASS F -  Diabetic nephropathy. 
 CLASS R -  Diabetic retinopathy. 
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 CLASS RF -  Retinopathy with nephropathy. 
 CLASS H -  Ischaemic heart disease. 
 CLASS T -  Prior kidney transplant. 
Table. 2 
Complications in pregnancy by type of diabetes.23 
Complications Normal GDM 
Type-1 
Dm 
Type-2 
Dm 
Con. Anomalies 1-2.2 1-2.2 10 10-15 
Miscarriages 5-15 - 9-17 8-15 
Still  birth 0.5 0.5 2.5 1-1.5 
Preterm 4-11 4-11 22-25 26-46 
Macrosomia 8-10 17-29 9-28 9-14 
Hypoglycemia - 1 5-25 51 
RDS - - 2-6 40 
NICU Care - 29 - 37-40 
 
Risk factors for GDM 
 Age > 30 yrs. 
 Obesity 22. 
 History of GDM during previous pregnancy. 
 History of LGA baby during previous pregnancy. 
 Family history of type - 2 DM. 
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 Primigravida 2,22,25. 
 Higher dietary fat with low carbohydrate intake during pregnancy. 
 Eating one or more egg / day before or during pregnancy increases 
the risk of GDM.24 
Screening for GDM 
 Done in high risk pregnancies. 
 Done by using glucose challenge test and glucose tolerance test. 
Glucose Challenge Test 
By using 50gms glucose challenge test without regard to time  of 
day/last meal between 24-28wks of pregnancy. A plasma glucose value 
of 140mg% or that of whole blood of 130mg% at 1hr is considered as a 
cut off point for consideration of a 75gm glucose tolerance test. 
The diagnosis of GDM is based on a 75gm GTT. A larger than usual 
glucose load (75gms) is advocated as there is an increased turnover of 
glucose in pregnant state2,26. 
Indications for GTT 
 Fasting glycosuria on one occasion before 20th wk and 2 or more 
occasions thereafter. 
 Following a positive screening test. 
 If RBS is >95mg/100ml. 
 If FBS is >126mg/dl and if it is confirmed on repeat test, there is 
no need to perform GTT. 
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Glucose Tolerance Test 
Method Used  
 The patient is advised to come with fasting for about 8 hrs. 
Before starting the procedure a blood sample is collected which 
gives the fasting blood sugar. Then the patient is asked to take about 75 
gm sugar, and 3 more blood samples are taken after 1hr, 2hr and 3hr 
respectively. 
Interpretation of Results: 
 Normal values - Fasting (60-100 mg/dl). 
 1hr value- <200 mg/dl. 
 2hr value - < 140 mg/dl. 
Table.3 
Diagnostic Criteria For GDM28 
        100 gm glucose          75 gm glucose 
Fasting  95 mg/dl.   95 mg/dl. 
1hr 180 mg/dl. 180 mg/dl. 
2hr 155 mg/dl. 155 mg/dl. 
3hr 140 mg /dl.         - 
 
Diagnosis is based on more than two values listed above. 
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Diagnostic Criteria for DM Prior To Pregnancy 
 Symptoms of DM + RBS > 200mg/dl. 
 FBS > 126mg/dl. 
 2hr PPBS > 200mg/dl during OGTT. (With 75gm glucose in 
water). 
Glycosylated Haemoglobin: 
HbA1C is a blood test to determine the level of haemoglobin that is 
sugar coated. As the lifespan of RBC is 120 days, HbA1C values reflect 
the adequacy of glucose control for the previous 4-6wks. HbA1C level >7 
indicate elevated glucose during the past 4-6wks and is associated with 
increased incidence of complications.29 Recent guidelines insist on 
maintenance of HbA1C level < 6.30 
Methods For Measuring HbA1C  
1. Methods based on structure differences 
a) Immunoassays. 
b) Affinity chromatography. 
2. Methods based on charge differences. 
a) Ion exchange chromatography. 
b) Electrophoresis. 
c) Isoelectric focussing. 
d) High pressure liquid chromatography. 
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Limitation of HBA1C Measurement 
Although HbA1C levels are a reliable indicator of recent average 
glycemic control, they do not provide information about the daily pattern 
of blood glucose fluctuation which is required for fine tuning of insulin 
doses.32 
Guidelines for treatment in DM complicating pregnancy 
Prepregnancy- 
Explain general risks and management of diabetes in pregnancy.   
Evaluate any additional risks2,14,20. 
 Evaluation of blood pressure. 
 Evaluation of renal status. 
 Evaluation of retinal status. 
 ECG. 
 Clinical evaluation of peripheral and autonomic neuropathy. 
 Clinical evaluation of hypoglycemic symptoms. 
 Clinical evaluation of peripheral vascular disease. 
Discuss effective contraception until good glucose control.  
Contraception methods1 
 Method of choice - Barrier method. 
Low dose oral contraceptive pills may be safely used. 
Folate supplementation (4-5mg) daily for at least 2 months before 
and during first trimester2, 16. 
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Antenatal 33 
 Screen for GDM ideally in all pregnancies. 
 Regular capillary glucose series. 
 Avoid oral hypoglycemic agents. 
 Appropriate diet. 
 Follow insulin regimen to keep capillary glucose levels as normal 
as possible. 
 Regular ophthalmological review. 
 Monitor for hypertensive disease. 
 Foetal surveillance. 
Tests of Fetal Well Being 34: 
 Counting of foetal movements done every night from 28wk. Ten 
movements in < 60min is reassuring. 
 Non stress test - Done twice weekly. Begin at 28-34 wks in patients 
with IDDM. Two heart rate accelerations in 20 min is reassuring. 
 Contraction stress test is done weekly. No heart rate deceleration in 
response to < 3 contractions in 10 min. 
 Ultrasound biophysical profile, done weekly. 
Labour and Delivery 
Timing can be delayed until term if blood sugar is controlled. 
Maintain good perinatal glucose control. 
Mode of delivery depends on maternal and foetal complications. 
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Postnatal 
 Insulin requirement decreases during postnatal period. 
 Continue CBG monitoring. 
 Encourage breast feeding. 
 Benefits of Breast Feeding: 
 Improved glucose metabolism. 
 Non insulin mediated use of glucose by mammary gland to 
synthesize lactose.35 
 Increased insulin sensitivity due to increased prolactin and 
decreased oestradiol. 
 Improved B cell function. 
 Improved lipid metabolism. 
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MANAGEMENT PROTOCOL FOR GDM 
                                       Screening 50gm GCT 
 
 
                                        >7.8mmol/lit (140 mg/dl)  
 
 
                                     OGTT- (Diagnostic) 
 
                        Normal                                   Abnormal 
  
                                            Sugar profile 
 
                          Normal                                 Abnormal 
 
 
                          Diet alone                         Diet and insulin 
 
(Monitor weekly sugar profile) 
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Management for DM complicating pregnancy: 
 Antenatal: 
Control of blood sugar remains the mainstay of management 
during the antenatal period. 
Methods used  
DIETARY MANAGEMENT - A meal plan to maintain euglycemia 
should be followed2, 36. Total calories 30-35 kcal/kg given as 3 meals and 
3 snacks daily. Diet should contain 55% carbohydrate, 20% protein, 25% 
fat (with <10% saturated fat). 
GLYBURIDE- A sulfonylurea which acts by closing potassium 
channels of the pancreatic beta cells causing calcium influx and secretion 
of insulin from storage granules37. It also decreases insulin resistance. 
Dose - 1.25 or 2.5 mg twice daily, max. dose upto10mg twice daily. 
INSULIN THERAPY- If PPBS is >150 mg/dl, in spite of dietary 
control, plain insulin is given subcutaneously in 3 divided doses started. 
Amount of insulin depends on blood sugar levels. 
Blood sugar should be controlled to maintain fasting blood sugar 
<95 mg/dl and postprandial <140 mg at 1hr, <120 mg at 2hr. 
Intrapartum 
Glucose infusion is provided to all patients in labour as 5%D in 
RL. (Rate -125 ml/ hr) 
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Bedside glucose monitor- Monitor every 2-4hrs in early labour and 
1-2hrs in active labour. For patients on insulin, continuous insulin 
infusion of regular insulin 25U in 250ml of saline (0.5-2.0U/hr). 
Continuous foetal monitoring is mandatory.38 
Postpartum 
Immediately after delivery of the placenta, there is a sudden loss of 
insulin resistance and the majority of patients will not require insulin for 
24-48 hrs. Once their fasting/postprandial capillary glucose starts to rise, 
insulin therapy should be restarted using one half to two thirds of the 
dosage that the patient was receiving before delivery. This initial dose is 
adjusted according to the patient’s response. 
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METHODOLOGY 
TITLE OF THE SYUDY: 
 Clinical profile of complications in newborn born to diabetic 
mothers based on their third trimester glycemic control – A study in 
patients admitted in Tirunelveli Medical College Hospital. 
AIM OF THE STUDY: 
 To study the pattern of complications in newborn born to diabetic 
mothers. 
 To assess the correlation between HbA1C level in diabetic mothers 
and complications in babies born to them. 
Type of Study 
 Cohort study. 
Study  Period  
The  study  was  conducted  for  a  period  of 12  months ( from  
Aug 2011 to  July 2012). 
Settings  
Babies  born  to  diabetic  mothers  were  examined  clinically  and  
by  biochemical  investigations  to  find  out  any  complications  due  to  
maternal  diabetes. Retrospectively,  mothers  third  trimester  glycemic  
control  was  assessed  by  perusal  of  previous  history  and  laboratory  
investigation  records  and also  by  doing  HbA1C levels  during  
postnatal  period. Correlation  between  the  incidence  of  complications  
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in  neonates  born  to  diabetic  mothers  was  assessed  with  third  
trimester   glycemic  control  of  the  mother. As HbA1C < 6 is considered 
as good glycemic control in recent guidelines, mothers in this study were 
classified as with HbA1C < 6 and with HbA1C > 6 for better correlation. 
Sample Size:  
52 babies  born  to  diabetic  mothers  who  came  under  the  
inclusion  criteria  were  included  in  the  study. 
Inclusion Criteria: 
1) Neonates born to gestational diabetic mothers. 
2) Neonates born to mothers with pre gestational diabetes. 
Exclusion Criteria: 
Complications in neonates born to diabetic mothers which reflect 
first trimester glycemic control  (e.g.) congenital malformation. 
Tools used: 
Investigations done in babies : 
 Blood sugar levels at 1hr, 2hr, 3hr, 6hr, 12hr, 24hr, 36hr and 48hr. 
 Serum bilirubin (Total, Direct and Indirect). 
 PCV at 1hr and 24hrs. 
 Serum calcium. 
 Laboratory investigations in mother: HbA1C was done in mothers 
as it gives the last trimester glycemic control. 
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Data Analysis: 
Data collected were entered in Excel spread sheet and analysed 
using SSPS version 16. Simple calculations like percentages, proportions 
and mean values were derived. Appropriate statistical tests like chi-square 
test, T test were used. 
  
 In this study, 52 cases were studied. Among those 52 cases, 
cases (98.1%) were included in my study in their first day of life as most 
of the babies included in this study were born in the same hospital where 
study was conducted and 1 case (1.9%) was included on second day of 
life. 
  
Age 
      1/365   
      2/365 
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OBSERVATION 
Table.4 
AGE 
Frequency Percentage 
51 98.1% 
1 1.9% 
Fig.1 
 
98.10%
1.90%
51 
 
1/365
2/365
 SEX 
  Out of the 52 cases studied 13 cases (25%) were females and 39 
cases (75%) were males.
       Sex 
Female 
Male 
 
 
 
75%
33 
 
 
Table. 5 
      Frequency       Percentage
13 25.0% 
39 75.0% 
Fig.2 
 
25%
 
 
FEMALE
MALE
 BOOKED/UNBOOKED
  Among the 52 cases
cases (94.2%) were unbooked.
  Booked / Unbooked
Booked 
Unbooked 
 
 
34 
: 
, 3 cases (5.8%) were booked cases and 49 
 
Table.6 
      Frequency           Percentage
3 5.8%
49 94.2%
 
Fig. 3 
 
 
94.20%
5.80%
BOOKED
UNBOOKED
 
 
 
 
 GDM/DM: 
 Among the mothers 
pregestational diabetes and 43 mothers (82.7%) were having gestational 
diabetes. 
GDM / DM
DM
GDM
 
 
 
 
35 
studied, 9 mothers (17.3) were having 
Table – 7 
 Frequency Percentage 
 9 17.3% 
 43 82.7% 
Fig.4 
 
82.70%
17.30%
 
GDM
DM
 TREATMENT DETAILS
  Out of the 52 cases, 47 cases (90.3 
(9.6%) were not treated. Among the treated cases, 19 cases (36.5%) were 
on diabetic diet and 28 cases (53.8%) were on insulin.
          Treatment 
Diet 
Insulin 
 
 
 
 
53.80%
36 
: 
%) were treated and 5 cases 
 
Table.8 
           Frequency          Percentage
    19     36.5% 
     28     53.8% 
Fig.5 
 
36.50%
9.60%
 
 
DIET 
INSULIN
NO TREATED
 COMPLIANCE: 
 Among the 47 treated cases, 37 cases were compliant and 10 cases 
were not compliant. Those who were not treated were included as not 
applicable. 
Compliance
COMPLIANT 
NOT COMPLIANT
NOT APPLICABLE
 
 
 
19.20%
37 
Table.9 
 Frequency Percentage
37 71.2%
 10 19.2%
 5 9.6%
(FIG – 6) 
 
71.20%
9.60%
 
 
 
 
 
COMPLAINT
NOT COMPLAINT
NOT APPLICABLE
 MODE OF DELIVERY
Among the 52 babies, 2 of them were
delivery, 6 of them were
were delivered by LSCS.
Mode of delivery
FORCEPS 
LN 
LSCS 
 
 
 
38 
: 
 delivered by
 delivered by labour naturalis and 44 of them 
 
Table – 10 
 Frequency Percentage
2 3.8%
6 11.5%
44 84.6%
FIG – 7 
 
3.80%
11.50%
84.60%
 forceps 
 
 
 
 
 
FORCEPS
LN
LSCS
 ASPHYXIA: 
 Out of the 52 cases,  
- 9 cases (17.3 %) were asphyxiated.
- 43 cases (82.7 %) were not asphyxiated.
ASPHYXIA
      YES 
      NO 
 
 
 
 
82.70%
39 
 
 
TABLE – 11 
 FREQUENCY PERCENTAGE
9    17.3% 
43    82.7% 
FIG – 8 
 
17.30%
 
 
ASPHYXIA
NO ASPHYXIA
 BIRTH INJURIES: 
 Out of the total no of cases,
6 cases had birth injuries. Out of them, 3 babies were delivered by 
normal labour, 2 babies were delivered by forceps delivery and 1 baby 
was delivered by caesarean 
46 cases did not have any birth injuries.
BIRTH INJURIES
YES 
NO 
 
40 
 
section. 
 
TABLE – 12 
 FREQUENCY PERCENTAGE
6 11.5%
46 88.5%
FIG – 9 
BIRTH INJURIES 
11.50%
88.50%
 
 
 
 
YES
NO
  
FETAL OUTCOME:
Out of the 52 cases included in the study
6 babies were born as preterm. Among these 6 
were born between 34 
weeks. 
46 babies were born as term babies.
FETAL OUTCOME
PRETERM 
TERM 
 
 
41 
 
 
babies, 4 babies 
– 37 weeks and 2 babies were born before 34 
 
TABLE – 13 
 FREQUENCY PERCENTAGE
6 11.5%
46 88.5%
FIG – 10 
11.50%
88.50%
 
 
 
 
PRETERM
TERM
  
GESTATIONAL AGE
Among the 52 babies studied,
3 babies (5.8 %) were small for gestational age.
21 babies (40.4 %) were appropriate for gestational age.
28 babies (53.8 %) were large for gestational age.
GEST. AGE 
SGA 
AGA 
LGA 
 
53.80%
42 
: 
 
 
 
TABLE – 14 
FREQUENCY PERCENTAGE
3 5.8% 
21 40.4% 
28 53.8% 
FIG – 11 
5.80%
40.40%
 
 
 
SGA
AGA
LGA
 MACROSOMIA: 
Among the 52 cases included in the study
28 babies (53.8 %) had macrosomia.
24 babies (46.2 %) did no
The maximum birth weight among babies wa
minimum birth weight among babies wa
weight was 3.57 kg.
TABLE – 15 
MACROSOMIA
YES 
NO 
 
46.20%
43 
 
 
t have macrosomia. 
s 4.42 kg and the 
s 1.62 kg .The mean birth 
 
 FREQUENCY PERCENTAGE
28 53.8% 
24 46.2% 
FIG – 12 
53.80%
 
 
MACROSOMIA
NO MACROSOMIA
 HYPOGLYCEMIA: 
In this study, the total no
documented- 23 cases (44.2%)
The total no. 
documented- 29 cases (55.8 %).
In this study, blood sugar values are taken at 1 hr, 2 hr, 3 hr, 6 hr, 9 
hr, 12 hr, 24 hr, 36 hr and 48 hrs. The maximum blood sugar value and 
minimum blood sugar value wer
calculated. Most of the hypoglyc
of life. 
 
55.80%
44 
. of cases in which hypoglycemia was 
. 
of cases in which hypoglycaemia was not 
 
 
Fig – 13 
e noted. Mean blood sugar value was 
emic episodes were seen in the first day 
 
44.20% HYPOGLYCEMIA
NO HYPOGLCEMIA
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VARIOUS  BLOOD  SUGAR VALUES TAKEN : (TABLE – 16) 
BLOOD SUGAR 
VALUE-AT 
MINIMUM 
VALUE 
MAXIMUM 
VALUE 
MEAN 
VALUE 
1 HR 32 97 64.04 
2 HR 27 121 67.10 
3 HR 22 156 80.10 
6 HR 25 158 91.94 
12 HR 37 156 98.21 
24 HR 71 176 107.19 
36 HR 62 168 103.38 
48 HR 72 178 111.77 
 
  
 HYPOCALCEMIA: 
Among the babies studied, 7 babies (13.5%) had hypocalce
45 babies (86.5 %) did no
calcium obtained was 11.56 mg/dl and the minimum value of calcium 
obtained was 5.24 mg/dl. The mean value of calcium was 9.07.
HYPOCALCEMIA
YES 
NO 
 
 
86.50%
46 
t have hypocalcemia. The maximum value of 
 TABLE – 17 
 FREQUENCY PERCENTAGE
7 13.5%
45 86.5%
FIG – 14 
 
13.50%
HYPOCALCEMIA
NO HYPOCALCEMIA
mia and 
 
 
 
 
 
 HYPERBILIRUBINEMIA
In this study, the number of babies who had hyperbilirubinemia 
was 17 and the number of babies who did no
was 35. 
HYPERBILIRUBINEMIA
    YES 
    NO 
 
 
 
 
67.30%
47 
: 
t have hyperbilirubinemia 
TABLE – 18 
 FREQUENCY PERCENTAGE
     17      32.7%
     35    67.3%
FIG – 15 
32.70%
HYPERBILIRUBINEMIA
NO HYPERBILIRUBINEMIA
 
 
 
 
 POLYCYTHEMIA: 
In this study, among the 52 cases 
4 babies (7.7%) had polycythemia.
48 babies (92.3%) did no
The maximum value of PCV was 70.67 and the minimum value of 
PCV was 46.07.The mean value was 54.43.
POLYCYTHEMIA
YES 
NO 
 
 
 
92.30%
48 
 
 
t have polycythemia. 
 
TABLE – 19 
 FREQUENCY PERCENTAGE
4 7.7% 
48 92.3%
FIG – 16 
7.70%
POLYCYTHEMIA
NO POLYCYTHEMIA
 
 
 
 RESPIRATORY DISTRESS SYNDROME
Among the babies studied, 5 babies (9.6%) had respiratory distress 
syndrome and 47 babies (90.4%) did no
syndrome. Among the 5 babies 4 were preterm and 1 was a term baby.
RDS 
YES 
NO 
 
 
 
49 
: 
t have respiratory distress 
TABLE – 20 
FREQUENCY PERCENTAGE
5 9.6% 
47 90.4% 
FIG – 17 
 
9.60%
90.40%
 
 
 
RDS
NO RDS
 GLYCOSYLATED HAEMOGLOBIN
Based on the STANDARDS OF MEDICAL CARE IN DIABETES 
-2012 and GLOBAL GUIDELINES PREGNANCY AND DIABETES, 
HbA1C which denotes good glycemic control was taken as < 6. Out of the 
52 cases studied, 30 cases had 
HbA1C 
< 6 
>6 
 
 
 
42.31%
50 
: 
HbA1C < 6 and 22 cases had HbA
TABLE – 21 
FREQUENCY PERCENTAGE
22 42.3% 
30 57.7% 
FIG – 18 
 
57.69%
1C > 6.  
 
 
HbA1C > 6
HbA1C <  6
 SEX              TABLE 
SEX 
      FEMALE 
       MALE 22 (56.4 %)
       TOTAL 30 (57.7 %)
 
INTERPRETATION :
Among the 30 babies born to mothers with poor glycemic control, 
22 babies were males and 8 babies were females.
Among the 22 babies born to mothers with good glycemic
17 babies were males and 5 babies were females.
     FIG – 19 
(P VALUE – 0.746, df 
0
5
10
15
20
25
FEMALE
8
51 
RESULTS 
– 22: 
HbA1C CATEGORY 
HIGHER 
( > 6 ) 
LOWER 
( < 6 ) 
8 (61.5 %) 5 (38.5 %) 13
 17 (43.6 %) 39 
 22 (42.3 %) 52 (100.0 %)
 
 
 
– 1) 
MALE
22
5
17
TOTAL 
 (100.0 %) 
(100.0 %) 
 
 control, 
 
HbA1C  >6
HbA1C <6  
52 
 
INFERENCE : 
In both the above categories, the number of male babies exceeds 
the number of female babies. Hence it is convincing that there is no 
correlation between the sex of the baby born to diabetic mothers and the 
maternal glycemic control. The statistical analysis done with the above 
data shows the P value of this variable as 0.746. This was not statistically 
significant. 
BOOKED / UNBOOKED: 
TABLE – 23 
BOOKED 
HbA1C CATEGORY 
TOTAL 
HIGHER ( > 6 ) LOWER ( < 6 ) 
YES 27 (55.1 %) 22 (44.9 %) 49 (100.0 %) 
NO 3 (100.0 %) 0 (0 %) 3 (100.0 %) 
TOTAL 30 (57.7 %) 22 (42.3 %) 52 (100.0 %) 
 
INTERPRETATION : 
Among the booked cases, 55.1% had higher HbA1C and 44.9% had 
lower HbA1C.  
In unbooked cases, 100% of cases had higher HbA1C values. 
 
 
  
  
(P VALUE-0.127, df-
INFERENCE: 
This seems to be highly correlating 
even booked their pregnancy, would not have gone for regular check up’s 
and would not have taken any treatment to keep 
control). But according to the 
variable is 0.127. This wa
small sample size. 
 
 
 
0
5
10
15
20
25
30
BOOKED
27
53 
FIG – 20 
1) 
( Those mothers who had not 
their blood sugar under 
statistical analysis, the P value for this 
s not statistically significant. This is due to the 
UNBOOKED
22
3
0
 
HbA1C >6
HbA1C <6 
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GDM / DM: 
 
TABLE – 24 
GDM / DM 
HbA1C CATEGORY 
TOTAL 
HIGHER ( > 6 ) LOWER ( < 6 ) 
DM 7 (77.8 %) 2 (22.2 %) 9 (100.0 %) 
GDM 23 (53.5 %) 20 (46.5 %) 43 (100.0 %) 
TOTAL 30 (57.7 %) 22 (42.3 %) 52 (100.0 %) 
 
INTERPRETATION : 
Among the 9 DM mothers, 7 mothers (77.8 %) had HbA1C value > 
6 and 2 mothers (22.2%) had HbA1C value < 6. 
Among the 43 GDM mothers, 23 mothers (53.5%) had HbA1C 
values > 6 and 20 mothers (46.5%) had HbA1C value < 6. 
 
 
  
 (P VALUE – 0.180, df
INFERENCE : 
Here it seems that whether DM or GDM, the number of cases with 
HbA1C value which implies poor glycemic control exceeds the number of 
cases with HbA1C value which implies good glycemic control. This 
indicates that the antenatal care is not adequate and also it indicates that 
the mothers are not aware of the complications associated with poor 
glycemic control during pregnancy. But when analysed, the P val
this variable was 0.180.
This was not statistically significant
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FIG – 21 
-1) 
 
. 
DM
20
7
2
 
ue for 
HbA1C >6
HbA1C <6 
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COMPLIANCE: 
TABLE – 25 
COMPLIANCE 
HbA1C CATEGORY 
TOTAL 
HIGHER ( > 6 ) LOWER ( < 6 ) 
COMPLIANT 16 (43.2 %) 21 (56.8 %) 37 (100.0 %) 
NOT COMPLIANT 9 (90.0 %) 1 (10.0 %) 10 (100.0 %) 
 NOT APPLICABLE 5 (100.0 %) 0 (0 %) 5 (100.0 %) 
TOTAL 30 (57.7 %) 22 (42.3 %) 52 (100.0 %) 
 
INTERPRETATION : 
Here, among those patients who were compliant with treatment, 
43.2% had higher HbA1C values and 56.8% had lower HbA1C values. 
Among those patients who were not compliant 90% had higher 
HbA1C values and 10% had lower HbA1C values. 
Not applicable implies those patients who were not treated. Among 
them 100% had higher HbA1C values.  
  
 (P VALUE-O.OO4, df
 
INFERENCE : 
Here it shows that those mothers who were compliant had 
values < 6, which indicates good glycemic control. The P value of this 
variable was 0.004. Statistically this observation was found to be highly 
significant. 
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FIG – 22 
COMPLIANCE 
-2) 
 
NOT 
COMPLIANT
NOT 
APPLICABLE
9
5
1
0
 
HbA1C 
HbA1C >6
HbA1C <6 
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TREATMENT: 
TABLE – 26 
TREATMENT 
HbA1C CATEGORY 
TOTAL 
HIGHER ( > 6 ) LOWER ( < 6 ) 
DIET 9 (47.4 %) 10 (52.6 %) 19 (100.0 %) 
INSULIN 16 (57.1 %) 12 (42.9 %) 28 (100.0 %) 
NOT TREATED 5 (100.0 %) 0 (0 %) 5 (100.0 %) 
TOTAL 30 (57.7 %) 22 (42.3 %) 52 (100.0 %) 
 
INTERPRETATION : 
According to the treatment given, the patients were divided into 3 
groups. 
In patients who were treated with diabetic diet, 47.4% cases had 
HbA1C values >6 and 52.6% cases had HbA1C values <6. 
In patients who were treated with insulin, 57.1% cases had HbA1C 
values >6 and 42.9% cases had HbA1C values <6. 
In patients who were not treated, 100% of cases had HbA1C values 
>6. 
 
  
 (P VALUE-0.105, df-
INFERENCE : 
Among the mothers who were on diabetic diet, about half of them 
had poor glycemic control. Among those mothers who were on insulin, 
more no of mothers had poor glycemic control. This may be due to the 
fact that outcome depends on various
Among the non treated mothers, all of them had poor glycemic
control. This seems to be correlating. However, the results were not 
statistically significant. The P value was 0.105.
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FIG – 23 
TREATMENT 
2) 
 other factors like compliance.
 
INSULIN NOT TREATED
16
5
12
0
 
 
 
HbA1C >6
HbA1C <6 
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MODE OF DELIVERY: 
TABLE – 27 
DELIVERY 
HbA1C CATEGORY 
TOTAL 
HIGHER ( > 6 ) LOWER ( < 6 ) 
FORCEPS 1 (50.0 %) 1  (50.0 %) 2 (100.0 %) 
LN 3 (50.0 %) 3 (50.0 %) 6 (100.0 %) 
LSCS 26 (59.1 %) 18 (40.9 %) 44 (100.0 %) 
TOTAL 30 (57.7 %) 22 (42.3 %) 52 (100.0 %) 
 
INTERPRETATION: 
In patients with HbA1C value >6,  
3.3% cases were delivered by forceps. 
10% cases were delivered by labour naturalis. 
86.6% cases were delivered by caesarean section. 
In patients with HbA1C value< 6, 
 4.5% cases were delivered by forceps. 
13.6% cases were delivered by labour naturalis. 
81.8% cases were delivered by caesarean section. 
  
 (P VALUE-O.892, df
INFERENCE : 
This shows that most of the diabetic pregnancies are delivered by 
caesarean section .This seems to be a good approach as the incidence of 
birth injuries in macrosomic babies could be avoided. 
This was not statistically significant.
The P value was 0.892.
 
0
5
10
15
20
25
30
FORCEPS 
1 1
61 
 
FIG – 24 
MODE OF DELIVERY 
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ASPHYXIA: 
TABLE – 28 
ASPHYXIA 
HbA1C CATEGORY 
TOTAL 
HIGHER ( > 6 ) LOWER ( < 6 ) 
YES 6 (66.7 %) 3 (33.3 %) 9 (100.0 %) 
NO 24 (55.8 %) 19 (44.2 %) 43(100.0 %) 
TOTAL 30 (57.7 %) 22 (42.3 %) 52 (100.0 %) 
 
INTERPRETATION : 
  Among the 9 babies who had experienced birth asphyxia, 6 babies 
(66.7%) were born to mothers with poor glycemic control and 3 babies 
(33.3%) were born to mothers with good glycemic control. 
Among the 43 babies who did not experience birth asphyxia, 24 
babies (55.8%) were born to mothers with poor glycemic control and 19 
babies (44.2%) were born to mothers with good glycemic control. 
  
 (P VALUE – 0.549, df 
INFERENCE : 
Here among the babies who had experienced birth asphyxia, most 
of them were born to diabetic mothers with poor glycemic control. But 
among the babies who did not have birth asphyxia also 24 babies were 
born to mothers with poor glycemic control. This might
more no of caesarean deliveries conducted in diabetic pregnancies. This 
was not statistically significant. The P value was 0.549.
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FIG – 25 
ASPHYXIA 
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 be due to the 
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BIRTH INJURIES: 
TABLE – 29 
INJURIES 
HbA1C CATEGORY 
TOTAL 
HIGHER ( > 6 ) LOWER ( < 6 ) 
YES 4 (66.7 %) 2 (33.3 %) 6 (100.0 %) 
NO 26 (56.5 %) 20 (43.5 %) 46 (100.0 %) 
TOTAL 30 (57.7 %) 22 (42.3 %) 52 (100.0 %) 
 
INTERPRETATION : 
Out of the 6 babies who had birth injuries in this study, 4 babies 
(66.7%) were born to mothers with poor glycemic control and 2 babies 
(33.3%) were born to mothers with good glycemic control. 
Out of the 46 babies who did not have any birth injuries, 26 babies 
(56.5%) were born to mothers with poor glycemic control and 20 babies 
(43.3%) were born to mothers with good glycemic control. 
  
 (P VALUE – 0.636, df 
INFERENCE : 
In this study among the babies who had birth injuries, majority of 
them were born to diabetic mothers with poor glycemic control. This 
implies that a good glycemic
babies born to diabetic mothers. But among the other group without birth 
injuries, 26 babies were born to mothers with poor glycemic control. This 
might be due to the more number of caesarean deliveries conduct
diabetic pregnancies. This was not statistically significant.
The P value was 0.549.
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GESTATIONAL AGE: 
TABLE – 30 
GESTATIONAL 
AGE 
HbA1C CATEGORY 
TOTAL 
HIGHER ( > 6 ) LOWER ( < 6 ) 
SGA 0 (0 %) 3 (100.0 %) 3 (100.0 %) 
AGA 4 (19.0) 17 (81.0 %) 21 (100 .0 %) 
LGA 26 (92.9 %) 2 (7.1 %) 28 (100.0 %) 
TOTAL 30 (57.7 %) 22 (42.3 %) 52 (100.0 %) 
 
INTERPRETATION : 
Among the 3 SGA babies in this study, all the babies were born to 
mothers with good glycemic control. 
Among the 21 AGA babies in this study, 4 babies (19.0%) were 
born to mothers with poor glycemic control and 17 babies (81.0%) were 
born to mothers with good glycemic control. 
Among the 28 LGA babies in this study, 26 babies (92.9%) were 
born to mothers with poor glycemic control and 2 babies (7.1%) were 
born to mothers with good glycemic control. 
  
 (P VALUE – 0.000, df
 
INFERENCE : 
From the above data it is clear that most of the LGA babies in this 
study were born to diabeti
implies that a good glycemic control is essential to have AGA baby. This 
was found to be statistically highly significant.
The P value was 0.000.
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FETAL OUTCOME: 
 
TABLE – 31 
FETAL 
OUTCOME 
HbA1C CATEGORY TOTAL 
 HIGHER ( > 6 ) LOWER ( < 6 ) 
PRETERM 2 (33.3%) 4 (66.7%) 6 (100.0%) 
TERM 29 (63.0%) 17 (37.0%) 46 (100.0%) 
TOTAL 30 (57.7%) 22 (42.3%) 52 (100.0%) 
 (P VALUE – 0.031, df – 1) 
 
INTERPRETATION : 
Among the 6 preterm babies in this study, 4 babies (66.7 %) were 
born to mothers with good glycemic control and 2 babies (33.3 %) were 
born to mothers with poor glycemic control. 
Among the 46 term babies in this study, 29 babies (63.0%) were 
born to mothers with poor glycemic control and 17 babies (37.0 %) were 
born to mothers with good glycemic control. 
  
  
INFERENCE : 
From the above analysis it is clear that there is no correlation 
between preterm deliveries and maternal glycemic
of causes for preterm deliveries of which Diabetes in pregnancy is one. 
Hence the incidence of preterm deliveries could not be prevented by strict 
maternal glycemic control alone. However the results were not 
statistically significant.
The P value was 0.064. 
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MACROSOMIA 
 
TABLE – 30 
MACROSOMIA 
HbA1C CATEGORY 
TOTAL 
HIGHER ( > 6 ) LOWER ( < 6 ) 
YES 26 (92.9 %) 2 (7.1 %) 28 (100.0 %) 
NO 4 (16.7 %) 20 (83.3 %) 24 (100.0 %) 
TOTAL 30 (57.7 %) 22 (42.3 %) 52 (100.0 %) 
 
INTERPRETATION : 
Out of the 28 macrosomic babies in this study, 26 babies (92.9%) 
were born to mothers with poor glycemic control and 2 babies (7.1%) 
were born to mothers with good glycemic control. 
Out of the 24 babies without macrosomia in this study, 20 babies 
(83.3%) were born to mothers with good glycemic control and 4 babies 
(16.7%) were born to mothers with poor glycemic control. 
  
 (P VALUE – 0.000, df 
 
INFERENCE : 
Here most of the macrosomic babies wer
with poor glycemic control. Macrosomic babies are usually associated 
with other complications such as birth asphyxia and birth injuries. Hence 
it indicates that it is mandatory to have a good glycemic control during 
pregnancy to avoid the complication of macrosomia. The results were 
found to be statistically highly significant.
The P value was 0.000.
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HYPOGLYCEMIA: 
 
TABLE – 31 
HYPOGLYCEMIA 
HbA1C CATEGORY 
TOTAL 
HIGHER ( > 6 ) LOWER ( < 6 ) 
YES 18 (78.3 %) 5 (21.7 %) 23 (100.0 %) 
NO 12 (41.4 %) 17 (58.6 %) 29 (100.0 %) 
TOTAL 30 (57.7 %) 22 (42.3 %) 52 (100.0 %) 
 
INTERPRETATION : 
Out of the 23 babies with hypoglycemia in this study, 18 babies 
(78.3%) were born to mothers with poor glycemic control and 5 babies 
(21.7%) were born to mothers with good glycemic control. 
Out of the 29 babies without hypoglycemia in this study, 17 babies 
(58.6%) were born to mothers with good glycemic control and 12 babies 
(41.4%) were born to mothers with poor glycemic control. 
  
 (P VALUE – 0.008, df 
 
INFERENCE : 
With the above 
to diabetic mothers is more common in pregnancies without good 
glycemic control. Prolonged hypoglyc
developmental outcome. Hypoglycemia may even le
infant if not corrected promptly. This 
glycemic control during pregnancy to avoid this complication in newborn 
born to diabetic mothers. This was found to have statistical significance.
The P value was 0.008.
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INTERPRETATION :
Among the 7 babies who had hypocalcemia in this study, 4 babies 
(57.1%) were born to mothers with poor glycemic
(42.9%) were born to mothers with good glycemic control.
Among the 45 babies without hypocalcemia in this study, 26 babies 
(57.8%) were born to mothers with poor glycemic control and 19 babies 
(42.2%) were born to mothers with good gl
(P VALUE - 0.975, df 
0
5
10
15
20
25
30
YES
4
74 
TABLE – 32 
HbA1C CATEGORY 
HIGHER ( > 6 ) LOWER ( < 6 ) 
4 (57.1 %) 3 (42.9 %) 
26 (57.8 %) 19(42.2 %) 
30 (57.7 %) 22 (42.3 %) 
 
 control and 3 babies 
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INFERENCE : 
The above interpretation shows that there is no definite correlation 
between incidences of hypocalcemia in neonates born to diabetic mothers 
with maternal glycemic control. This is because hypocalcemia in 
newborn is influenced by various other factors too. This was not 
statistically significant. 
The P value was 0.975. 
HYPERBILIRUBINEMIA: 
TABLE – 33 
HYPERBILIRUBINEMIA 
HbA1C CATEGORY 
TOTAL HIGHER 
 ( > 6 ) 
LOWER  
( < 6 ) 
YES 7 (41.2 %) 10 (58.8 %) 17 (100.0 %) 
NO 23 (65.7 %) 12 (34.3 %)   35 (100.0 %) 
TOTAL 30 (57.7 %) 22 (42.3 %) 52 (100.0 %) 
 
INTERPRETATION : 
In this study, among the 17 babies who had hyperbilirubinemia, 10 
babies (58.8%) were born to mothers with good glycemic control and 7 
babies (41.2%) were born to mothers with poor glycemic control. 
 Among the 35 babies who did no
babies (65.7%) were born to mothers with poor glycemic
babies (34.3%) were born to mothers with good glycemic control.
(P VALUE – 0.093, df 
INFERENCE : 
From the above details it is clear that there is no correlation for the 
above variables. This is because the
newborn are various. There were many other causes for 
hyperbilirubinemia in this study, (e.g.) 2
and one baby had RH incompati
This was not statistically significant.
The P value was 0.093.
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INTERPRETATION :
Out of the 4 babies who had polycythemia in this study, 2 babies 
(50.0%) were born to mothers with poor glycemic control and 2 babies 
(50.0%) were born to mothers with good glycemic control.
Out of the 48 babies who did not have polycythemia in this study,
28 babies (58.3%) were born to mothers with poor glycemic control and 
20 babies (41.7%) were born to mothers with good glycemic control.
(P VALUE – 0.746, df 
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TABLE – 34 
HbA1C CATEGORY 
 ( > 6 ) LOWER ( < 6 ) 
2 (50.0 %) 2 (50.0 %) 
28 (58.3 %) 20 (41.7 %) 
30 (57.7 %) 22 (42.3 %) 
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INFERENCE : 
The data given above shows that there is no correlation between 
polycythemia in newborn and maternal blood sugar. This is because 
polycythemia in newborn is influenced by many factors. In this study 
among the 4 cases with polycythemia, 1 was an IUGR baby. This was not 
statistically significant. The P value was 0.746. 
RESPIRATORY DISTRESS SYNDROME: 
TABLE – 35 
RDS 
HbA1C CATEGORY 
TOTAL 
HIGHER ( > 6 ) LOWER ( < 6 ) 
YES 1 (20.0 %) 4 (80.0 %) 5 (100.0 %) 
NO 29 (61.7 %) 18 (38.3 %) 47 (100.0 %) 
TOTAL 30 (57.7 %) 22 (42.3 %) 52 (100.0 %) 
 
INTERPRETATION : 
Among the 5 babies who had respiratory distress syndrome in this 
study, 4 babies (80.0%) were born to mothers with good glycemic control 
and only one baby (20.0%) was born to mother with poor glycemic 
control. 
 
 
 Among the 47 babies who did no
syndrome in this study, 29 babies (61.7%) were born to mothers with 
poor glycemic control and 18 babies (38.3%) were born to mothers with 
good glycemic control.
(P VALUE – 0.073, df 
INFERENCE : 
The above analysis shows that th
incidence of respiratory distress syndrome in neonates born to diabetic 
mothers and maternal glycemic control. This is due to the various causes 
of respiratory distress syndrome in newborn. All the 5 babies with 
respiratory distress syndrome in this study were delivered as preterm. 
This was not statistically significant. The P value was 0.073.
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DISCUSSION 
Diabetes mellitus complicating pregnancy is a global problem and 
this disease progression is in an increasing trend. Among the pregnancies 
that are complicated by diabetes, 80% accounts for gestational diabetes 
and 20% accounts for pre gestational diabetes. The complications that 
occur, both in diabetic mothers during pregnancy and neonates born to 
them are unique39. Various studies are being conducted worldwide on the 
complications of diabetic pregnancies, and more changes are being made 
in the treatment modalities for a fine tuning. Both the treating 
obstetricians and paediatricians should be familiar with the newer 
guidelines in the management of diabetes complicating pregnancies. 
Here an attempt was made to describe the pattern of complications 
in newborn born to diabetic mothers and emphasize the need for a strict 
glycemic control during pregnancy and careful follow up of newborn 
during the early neonatal period for early diagnosis of the complications. 
Totally 52 babies born to diabetic mothers and admitted in 
Tirunelveli medical college hospital nursery during the study period was 
analysed. According to the American diabetic association guidelines, 
diabetic mothers were categorised as 2 groups  
Mothers with HbA1C values < 6. 
Mothers with HbA1C values > 6. 
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The complications in newborn delivered by these two groups of 
mothers were compared and analysed to indicate the impact of maternal 
glycemic levels on their newborn. In this study out of the 52 cases, 30 
cases had HbA1C < 6 and 22 cases had HbA1C > 6. The maximum 
HbA1C value was 11.46 and the minimum HbA1C value was 4.51. The 
mean HbA1C value was 7.52.  
AGE 
Most of the babies in the present study were included on day 1 of 
life as the blood sugar values were taken starting from first hour of life. 
Only one baby was included on the second day as it was a referred case. 
In other studies referred, age of the mothers had been taken as a variable. 
SEX 
In this study among the babies born, 75% were boys and 25% were 
girls. There is no difference in the incidence of complications between 
boys and girls. Also, there is no predilection for either sex in both group 
of mothers included in the study. The sex of the baby born is not related 
to the glycemic values of the mother. 
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GDM / DM 
TABLE – 38 
STUDIES GDM DM 
Aarumugam et al40 92.7 % 7.3 % 
Banerjee et al41 73.3% 26.6% 
Kavitha et al42 64.8 % 35.1 % 
Akhlagi et al 27.0 % 73.0 % 
Abdulbari et al 16.3 % 83.7 % 
My study 82.7 % 17.3 % 
 
In most of the studies the percentage of GDM mothers is greater 
than the percentage of DM mothers. In this study too, it is the same. But 
in the studies from Middle East countries, the incidence of DM is more 
than GDM. This might be due to their dietary habits and their lifestyle. 
TREATMENT 
In the present study, 36.5 % of mothers were treated with diabetic 
diet, 53.8 % of mothers were treated with insulin and 9.6 % were not 
treated. In study done by Alam et al43 at National Institute of Child 
Health, Karachi (Aug 1999 to Jan 2000), 12.5 % of mothers were treated 
with diabetic diet, 47.5 % of mothers were treated with insulin and 40.0 
% were not treated. This implies that more number of mothers are 
attending antenatal check-up regularly and are compliant in our place. 
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MODE OF DELIVERY 
 In this study 84.6 % of babies were delivered by LSCS, 11.5 % of 
babies were delivered by LN and 3.8 % of babies were delivered by 
forceps. In Alam et al study 55.0 % of babies were delivered by LSCS 
and 45.0 % of babies were delivered by LN. In Akhlagi et al44 study 
conducted at Mashad university of medical sciences, Iran (Jan 2001 – 
April 2002), 79.8 % of babies were delivered by LSCS and 20.2 % of 
babies were delivered by LN. This is comparable with the present study. 
ASPHYXIA 
 In this study 17.3 % of babies experienced asphyxia. In Alam et al 
study conducted at National Institute of Child Health, Karachi 15.0 % in 
the study has experienced asphyxia. This is comparable with the present 
study. 
BIRTH INJURIES 
 In this study 11.5 % of babies had birth injuries. In a study by 
Abdul et al45 conducted at antenatal clinics of women’s hospital, Qatar, 
11.0 % of babies had birth injuries. In Alam et al study 17.5 % of babies 
had birth injuries. This is comparable with the present study. 
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FETAL OUTCOME 
TABLE – 39 
STUDIES PRETERM TERM 
Getu et al 25.0 % 75.0 % 
Akhlagi et al  29.4 % 70.6 % 
Abdul et al 20.9 % 79.1 % 
 
In this study 11.5 % of babies were born as preterm and 88.5 % of 
babies were born as term. This is comparable with the above studies. 
GESTATIONAL AGE 
In this study 53.8 % of babies were LGA, 40.4 % of babies were 
AGA and 5.8 % of babies were SGA. In Alam et al study 45.0 % of 
babies were LGA, 50.0 % of babies were AGA and 5.0 % of babies were 
SGA. This is comparable with the present study. 
HYPOGLYCEMIA 
 In this study 44.2 % of babies had hypoglycemia. In Akhlagi et al 
study 50.4 % of babies had hypoglycemia. In Alam et al study 35.0 % of 
babies had hypoglycemia. This is comparable with the present study. 
HYPOCALCEMIA 
 In this study 13.5 % of babies had hypocalcemia. In Alam et al 
study 15.0 % of babies had hypocalcemia. This is comparable with the 
present study. 
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HYPERBILIRUBINEMIA 
 In this study 32.7 % of babies had hyperbilirubinemia. In Alam et 
al study 30.0 % of babies had hyperbilirubinemia. This is comparable 
with the present study. 
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LIMITATIONS OF THE STUDY 
1. Complications due to impaired first trimester glycemic control such as 
congenital malformations were not included in this study. 
2. Incidence of IUD, Abortion and still born were not taken in this study. 
3. Incidence of Hypertrophic cardiomyopathy, which occurs due to poor 
glycemic control in the third trimester, could not be found out because 
of the non availability of echocardiography. 
4. Another third trimester complication, Lazy left colon syndrome was 
not included in this study. 
5. Foetal insulin levels in the cord blood sample to confirm 
hyperinsulinemia as the cause for the complications was not done. 
6. The sample size of this study was small and it was difficult to compare 
the complications in mothers with good glycemic control against the 
complications in mothers with poor glycemic control. 
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CONCLUSION 
Complications in newborn born to diabetic mothers are an 
emerging but preventable problem that seeks more importance. 
Gestational diabetes is more common than pregestational diabetes. 
The babies included in the present study had significant number of 
complications especially in neonates born to mothers with poor glycemic 
control. 
Diabetic mothers who were treated and who were compliant had 
fewer complications. 
There was no sex predilection for incidence of complications. 
Out of all the complications, macrosomia and hypoglycaemia had 
good correlation with maternal glycemic levels. 
Asphyxia and birth injuries were more common among 
macrosomic babies. 
Macrosomic babies are usually associated with other complications 
and hence should be admitted in nursery for close monitoring. 
Caesarean deliveries were more common among diabetic mothers. 
Hypocalcemia, hyperbilirubinemia and polycythemia in infants 
born to diabetic mothers were not correlating with maternal blood sugar 
control as these complications could be caused by various other reasons. 
Most of the complications are preventable and hence a meticulous 
antenatal care is essential. 
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Early recognition, precise assessment and appropriate management 
of complications as per guidelines would reduce the mortality and 
morbidity among babies born to diabetic mothers.                                     
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PROFORMA 
Name                         : 
Age / Sex                  :  
Address                      : 
Antenatal Details    : 
Married since – 
Consanguinity – 
Age during conception – 
Previous IUD / Abortions / Still birth – 
Booked and Immunised / Not – 
Confirmation of pregnancy – 
Gestational Diabetes / Pre gestational Diabetes – 
Time of diagnosis – 
Treatment details – 
Compliance – 
Natal Details: 
Mode of delivery – Normal labour/ Foreceps/ Vaccum/ Emergency LSCS 
/ Elective LSCS. 
Place of delivery. 
Liquor – Clear / Meconium stained. 
Birth injuries. 
Perinatal hypoxia. 
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Fetal outcome – Abortion/ IUD/ Still born/Term delivery/ Preterm 
delivery. 
Clinical examination of newborn : 
AGA / SGA / LGA. 
IUGR – Yes / No. 
Birth weight. 
Head circumference. 
Chest circumference. 
Oesophageal patency. 
Anal patency. 
Caput / Cephalhematoma / Subgaleal bleed. 
Birth injuries – Fracture humerus / Fracture clavicle / Fracture femur / 
Erb’s palsy/ Klumpkey’s palsy. 
Seizures – Yes / No. 
Respiratory distress – Yes / No. 
Cyanosis – Yes / No. 
Icterus – Yes / No. 
Plethora – Yes / No. 
Central Nervous System – Alert / Drowsy. 
Laboratory investigations   : 
In Mother      : HbA1c      . 
In Neonates  : 
96 
 
Blood Sugar Values at 1hr, 2hr, 3hr, 6hr, 12hr, 24hr, 36hr and 48hr. 
Serum Bilirubin Values – Total, Direct and Indirect. 
PCV Values at 1hr and 24 hr. 
Serum Calcium Values. 
Chest Radiography (in babies with respiratory distress). 
 
 
     
 
Age Sex Delivery HAB1C Hypoglycemia Polycytemia
1 Female Normal 6 No No
2 Male Normal 7 No No
3 Female Normal 8 Yes Yes
4 Male Normal 6 No No
5 Female Normal 7 Yes Yes
6 Male Normal 8 No No
HBA1C Hypoglycemia
Controlled 25%
Notcontrolled 75%
Eye Sight Affected %
one 15%
two 20%
Three 25%
Four 30%
Five 10%
fever % affected
male 40%
female 60%
Medicinal practises in India
Eye sight Vs affected children % 
60%
fever vs % affected
25%
75%
HBA1C Vs Hypoglycemia
Controlled Notcontrolled
24%
29%
35%
12%
Eye sight Vs affected children % 
Age wise
two Three Four Five
40%
fever vs % affected
male female
S.NO    AGE    SEX ADDRESS BOOKED GDM/DM DIAG-AT        TREATMENT     COMPLIANCE DELIVERY   HbA1C ASPHYXIA INJURIES   B.WT FETAL OUTCOME M.SOMIA HYPOGLY HYPOCAL HYPERBIL     RDS POLYCY      1hr     2hr      3hr      6hr     12hr     24hr      36hr      48hr calcium     PCV
1 . 1/365 Male Kayathar Yes GDM 7th mon Diabetic diet Not  compliant LSCS 5.7 No Nil 3.32 Term AGA No Yes No No No No 57 32 46 75 94 82 88 90 9.86 52.5
2 . 1/365   Male Palai Yes DM 2yrs Insulin Compliant LSCS 5.25 No Nil 3.04 Term AGA No Yes No Yes No No 62 73 56 31 105 98 62 78 10.2 56.23
3 . 1/365 Male Manur Yes GDM 9th mon Diabetic diet Compliant LSCS 5.26 No Nil 2.61 Term AGA No No Yes No No No 72 56 105 88 80 75 110 98 6.4 49.06
4 . 1/365 Male T.Veli Yes GDM 9th mon Insulin Compliant LSCS 10.48 No Nil 4.38 Term LGA Yes Yes No Yes No No 48 31 27 108 72 85 76 79 9.21 53.78
5 . 1/365 Male K.Patti Yes GDM 8th mon Insulin Compliant LSCS 4.95 No Nil 2.31 Term SGA No No No No No No 85 77 112 98 104 152 99 80 9.73 47
6 . 1/365 Female Sivagiri No GDM 7th mon Insulin Not  compliant LSCS 7.22 No Nil 4.04 Term LGA Yes No No No No No 62 78 103 128 91 109 88 79 10.85 51.69
7 . 1/365 Male N.Neri Yes GDM 7th mon Diabetic diet Compliant LN 5.41 No Nil 2.11 Preterm AGA No No No Yes Yes No 78 64 83 62 108 71 128 135 9.86 46.07
8 . 1/365 Male Kayathar Yes GDM 9th mon Insulin Compliant LSCS 5.02 No Nil 3.71 Term AGA No No No No No No 82 114 91 70 156 98 120 142 7.91 52.47
9 . 1/365 Female Ambai Yes GDM 7th mon Not treated            - LSCS 11.09 No Nil 4.28 Term LGA Yes Yes No No No No 34 53 107 65 82 110 98 144 10.79 50.12
10 . 1/365 Female Tenkasi Yes GDM 8th mon Diabetic diet Not  compliant LN 7.28 Yes Yes 4.01 Term LGA Yes Yes No Yes No No 47 27 35 82 79 92 88 72 7.42 55
11 . 2/365 Male Pettai Yes DM 10yrs Insulin Compliant Foreceps 11.46 Yes Yes 4.27 Term LGA Yes Yes Yes Yes No Yes 51 29 22 54 84 75 106 94 5.7 68.25
12 . 1/365 Male K.Patti Yes GDM 9th mon Insulin Not  compliant LSCS 8.27 No Nil 4.18 Term LGA Yes Yes No No No No 37 78 124 97 115 82 72 127 9.87 48.04
13 . 1/365 Male Ambai Yes DM 5yrs Insulin Compliant LSCS 10.93 Yes Nil 4.05 Term LGA Yes No Yes No No No 68 92 133 108 99 113 97 75 6.4 54.7
14 . 1/365 Male Kadayam Yes GDM 7th mon Diabetic diet Compliant LSCS 5.12 No Nil 2.07 Preterm AGA No No No Yes Yes Yes 84 71 78 93 98 102 87 73 10.28 70.67
15 . 1/365 Male Sivagiri Yes GDM 7th mon Insulin Compliant LSCS 4.51 No Nil 3.12 Term AGA No No No No No No 92 86 118 97 72 126 168 156 8.64 51.45
16 . 1/365 Male Manur Yes GDM 9th mon Not treated              - LSCS 10.15 No Nil 4.14 Term LGA Yes No No Yes No Yes 84 67 102 126 84 146 97 112 10.32 70.08
17 . 1/365 Female T.Veli Yes GDM 4 Days Insulin Compliant LSCS 7.41 No Nil 4.28 Term LGA Yes No No No No No 97 78 127 109 88 132 118 137 8.42 53.73
18 . 1/365 Male Valliyur Yes GDM 7th mon Diabetic diet Compliant Foreceps 5.9 Yes Yes 4.07 Term LGA Yes Yes No Yes No No 44 37 86 112 91 108 72 96 9.65 48.12
19 . 1/365 Male K.Patti Yes GDM 9th mon Diabetic diet Compliant LSCS 9.17 No Nil 4.23 Term LGA Yes Yes No No No No 49 53 47 25 37 76 105 84 11.56 57.94
20 . 1/365 Male Tenkasi Yes GDM 3 Days Not treated              - LSCS 8.21 No Nil 4.19 Term LGA Yes Yes No No No No 35 57 92 136 114 157 94 98 9.45 58.34
21 . 1/365 Female Ambai Yes GDM 9th mon Insulin Not  compliant LSCS 11.08 No Nil 4.03 Term LGA Yes Yes No No No No 52 36 40 76 105 89 92 96 10.42 51.73
22 . 1/365 Male K.Kurichi Yes GDM 7th mon Insulin Compliant LSCS 5.51 No Nil 3.87 Term AGA No Yes No No No No 61 56 27 38 86 74 108 87 9.76 62.16
23 . 1/365 Male Palai Yes DM  2 yrs Insulin Compliant LSCS 7.15 Yes Yes 4.38 Term LGA Yes Yes No No No No 58 31 64 112 91 146 109 124 8.71 47.98
24 . 1/365 Male S.vaikun No GDM 9th mon Diabetic diet Not  compliant LSCS 10.22 No Nil 4.01 Term LGA Yes No No No No No 76 104 94 121 86 102 92 98 7.94 54.72
25 . 1/365 Male Tenkasi Yes GDM 7th mon Diabetic diet Compliant LSCS 4.86 No Nil 3.17 Term AGA No No No No No No 84 65 107 86 80 92 76 91 10.78 59.41
26 . 1/365 Female Pettai Yes GDM 7th mon Diabetic diet Compliant LSCS 5.69 No Nil 3.45 Term AGA No No No Yes No No 74 68 79 127 148 97 110 96 9.28 54.3
27 . 1/365 Male Ambai Yes GDM 7 Days Insulin Compliant LSCS 9.18 No Nil 4.21  Term LGA Yes Yes  Yes Yes No No 58 32 64 105 86 82 107 118 6.76 57.58
28 . 1/365 Male V.Puram Yes GDM 8th mon Diabetic diet Compliant LSCS 5.04 No Nil 2.14 Preterm AGA No No No No Yes No 68 94 75 99 132 101 86 97 9.86 49.71
29 . 1/365 Female Alangulam Yes DM 3 yrs Insulin Compliant LSCS 10.52 No Nil 4.03 Term LGA Yes No No No No No 92 65 99 108 86 114 135 121 10.43 55.6
30 . 1/365 Male Manur Yes DM 5 yrs Insulin Compliant LSCS 9.82 No Nil 1.82 Preterm AGA No No No Yes Yes No 80 76 105 98 74 97 112 120 8.6 50.37
31 . 1/365 Female Tenkasi Yes GDM 7th mon Diabetic diet Compliant LN 6.56 No Nil 3.21 Term AGA No No No No No No 77 96 124 102 97 118 162 125 8.25 52.11
32 . 1/365 Male K.Patti Yes GDM 9th mon Diabetic diet Compliant LSCS 10.29 No Nil 4.4 Term LGA Yes Yes No No No No 54 27 33 78 105 86 80 94 10.48 58.44
33 . 1/365 Male Sivagiri Yes GDM 7th mon Insulin Compliant LSCS 5.42 No Nil 2.75 Term AGA No No Yes Yes No Yes 58 82 66 114 109 89 132 104 5.24 67.43
34 . 1/365 Male Kayathar Yes GDM 7th mon Insulin Compliant LSCS 4.77 No Nil 2.23 Term SGA No No No No No No 84 108 72 96 128 86 112 168 9.74 52.79
35 . 1/365 Male S.vaikun Yes GDM 9th mon Diabetic diet Compliant LN 9.44 Yes Yes 4.16 Term LGA Yes Yes No Yes No No 59 76 37 104 152 107 98 134 8.91 50.46
36 . 1/365 Male Tenkasi Yes GDM 4 Days Insulin Compliant LSCS 9.16 No Nil 4.32 Term LGA Yes Yes No No No No 47 29 38 86 64 108 87 126 10.21 53.7
37 . 1/365 Female S.Kulam Yes DM 2 yrs Insulin Compliant LSCS 5.68 No Nil 3.75 Term AGA No No No No No No 69 92 144 121 97 127 102 96 9.85 57.55
38 . 1/365 Female Kadayam Yes GDM 7th mon Diabetic diet Not  compliant LSCS 10.21 No Nil 4.08 Term LGA Yes No Yes No No No 96 84 117 132 114 96 148 165 6.1 47
39 . 1/365 Male R.Palayam Yes GDM 7th mon Insulin Compliant LN 4.99 Yes Nil 2.02 Preterm SGA No No Yes Yes No No 70 55 94 128 105 99 84 116 5.54 54.13
40 . 1/365 Male Tenkasi Yes DM 3 yrs Insulin Compliant LSCS 11.12 No Nil 4.27 Term LGA Yes Yes No No No No 32 41 76 30 108 136 97 125 9.76 56.02
41 . 1/365 Male Ambai Yes GDM 9th mon Insulin Not  compliant LSCS 6.07 No Nil 2.94 Term AGA No No No No No No 84 76 82 111 86 127 104 137 10.08 57.9
42 . 1/365 Male S.Malli No GDM 9th mon Diabetic diet Not  compliant LSCS 8.24 No Nil 2.61 Term AGA No No No No No No 76 112 68 97 146 114 123 144 9.36 56.92
43 . 1/365 Female Panakudi Yes GDM 7th mon Diabetic diet Compliant LSCS 5.29 No Nil 3.8 Term AGA No No No No No No 81 87 95 62 108 102 84 99 8.45 51.72
44 . 1/365 Male V.M.Sath Yes GDM 7th mon Insulin Compliant LSCS 4.86 No Nil 1.62 Preterm AGA No No No Yes Yes No 56 92 78 104 82 79 101 132 11.42 54.1
45 . 1/365 Male K.kulam Yes GDM 5 Days Insulin Compliant LSCS 6.37 No Nil 4.01 Term LGA Yes Yes No No No No 52 60 32 38 84 109 87 92 10.96 51.49
46 . 1/365 Male Tenkasi Yes GDM 4 Days Not treated              - LSCS 10.46 No Nil 4.3 Term LGA Yes No No No No No 74 112 156 98 114 132 167 156 8.4 57.2
47 . 1/365 Male V.Puram Yes GDM 7th mon Not treated Compliant LSCS 9.23 No Nil 4.24 Term LGA Yes Yes No No No No 36 42 26 38 75 124 96 88 9.05 52.34
48 . 1/365 Male Manur Yes GDM 7th mon Diabetic diet Compliant LN 5.89 Yes Yes 4.25 Term LGA Yes Yes No Yes No No 54 62 35 42 84 76 64 125 8.23 50.4
49 . 1/365 Male Ambai Yes DM 6 yrs Insulin Compliant LSCS 9.42 No Nil 4.31 Term LGA Yes Yes No No No No 32 40 76 102 86 148 114 178 10.09 48.76
50 . 1/365 Female K.Patti Yes GDM 8th mon Insulin Compliant LSCS 5.08 No Nil 2.7 Term AGA No No No Yes No No 66 52 89 158 96 112 97 90 9.47 52.81
51 . 1/365 Female Ambai Yes GDM 8th mon Insulin Compliant LSCS 5.22 No Nil 3.74 Term AGA No No No No No No 70 121 104 98 146 140 105 123 8.54 58
52 . 1/365 Male Manur Yes GDM 8th mon Diabetic diet Not  compliant LSCS 9.49 Yes Nil 4.42 Term LGA Yes Yes No No No No 32 63 75 108 94 176 132 98 8.9 50.8
